Literature DB >> 6231924

Insensitivity of cardiac phosphofructokinase to adrenergic activation in Zucker rats. A post-receptor defect.

G S Patten, S Rattigan, O H Filsell, M G Clark.   

Abstract

The apparent insensitivity of phosphofructokinase to activation by adrenaline in hearts from genetically obese Zucker (fa/fa) rats [Patten, Filsell & Clark (1982) Metab. Clin. Exp. 31, 1137-1141] was examined in detail. Perfusion of hearts from obese (fa/fa) animals with medium containing 1nM-100 microM-adrenaline for 4 min did not significantly activate phosphofructokinase, but fully activated glycogen phosphorylase. Activation of phosphofructokinase occurred in hearts from lean (Fa/?) animals, with half-maximal activation at 10nM-adrenaline. Binding characteristics of cardiac alpha 1-adrenergic receptors were comparable between lean and obese animals. Properties of phosphofructokinase from obese and lean hearts were similar. High extracellular Ca2+ concentration, which activated phosphofructokinase in hearts from lean animals and phosphorylase in all hearts, failed to activate phosphofructokinase in hearts from obese rats. The data indicate that the failure of adrenaline to activate phosphofructokinase in hearts from obese (fa/fa) rats results from a post-receptor defect in the as-yet unidentified Ca2+-dependent phosphofructokinase-activating reactions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231924      PMCID: PMC1153363          DOI: 10.1042/bj2180483

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

Review 1.  Regulation of glycolysis in skeletal muscle.

Authors:  A Ramaiah
Journal:  Life Sci       Date:  1976-08-15       Impact factor: 5.037

2.  Alpha-adrenergic receptors in rat myocardium. Identification by binding of [3H]dihydroergocryptine.

Authors:  R S Williams; R J Lefkowitz
Journal:  Circ Res       Date:  1978-11       Impact factor: 17.367

3.  Epinephrine activation of phosphofructokinase in perfused rat heart. Properties of the activated and nonactivated forms and the interconverting reactions.

Authors:  M G Clark; O H Filsell; G S Patten
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

4.  Epinephrine activation of phosphofructokinase in perfused rat heart.

Authors:  G S Patten; O W Filsell; M G Clark
Journal:  FEBS Lett       Date:  1981-11-30       Impact factor: 4.124

5.  Epinephrine regulation of phosphofructokinase in perfused rat heart. A calcium ion-dependent mechanism mediated via alpha-receptors.

Authors:  G S Patten; O H Filsell; M G Clark
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

6.  Insulin-resistance in heart and skeletal muscles of genetically obese Zucker rats.

Authors:  M Crettaz; D Zaninetti; B Jeanrenaud
Journal:  Biochem Soc Trans       Date:  1981-12       Impact factor: 5.407

7.  alpha-Adrenergic reduction of cyclic adenosine monophosphate concentrations in rat myocardium.

Authors:  A M Watanabe; D R Hathaway; H R Besch; B B Farmer; R A Harris
Journal:  Circ Res       Date:  1977-06       Impact factor: 17.367

8.  Cyclic AMP-dependent and cyclic AMP-independent antagonism of insulin activation of cardiac glycogen synthase.

Authors:  C Ramachandran; K L Angelos; D A Walsh
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

9.  Stable cholinergic-muscarinic and alpha-adrenergic inhibition of rat parotid adenylate cyclase.

Authors:  Y Oron; S Creacy; J Kellogg; J Larner
Journal:  J Cyclic Nucleotide Res       Date:  1980

10.  Epinephrine activation of phosphofructokinase in perfused rat heart independent of changes in effector concentrations.

Authors:  M G Clark; G S Patten
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

View more
  1 in total

1.  Catecholamines and Ca2+ mediate an increase in activity and reactive thiols of rat heart phosphofructokinase.

Authors:  M G Clark; S Rattigan; G S Patten; O H Filsell
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.